In a world of increasing fragmentation and polarisation, the 78th World Health Assembly, starting Monday, will present itself ...

Singapore, Hong Kong, China, and Thailand are witnessing a spike in Covid-19 cases. In Singapore, the surge in infections is driven by LF.7 and NB.1.8 — both descendants of JN.1 variant, which is a ...

Investors reacted positively to the news, as the FDA’s approval not only enhances Novavax’s product offering but also solidifies its partnership with Sanofi, a key player in the vaccine market. The ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

The World Health Organization is opening its annual meeting of government ministers and other top envoys facing one of the ...

The variant JN.1 was first detected in 2023 which led to increase in COVID-19 cases in Asian countries like Singapore, China, ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

The early months of Donald Trump’s presidency have brought sweeping changes to the country’s scientific and medical landscape ...

Høeg has been skeptical of the safety and value of some vaccines and mandates, raising questions about her approach at the ...

Gaithersburg’s Novavax has secured formal regulatory approval for its Covid vaccine. It's a major win, after the FDA delayed ...

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based covid vaccine produced by pharmaceutical giant Novavax.